Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXHL2300195	BI685509片	Avenciguat	Tablet	Chemical Drugs(1)	Import Drug Application	2023-08-22					view
JXHL2300194	BI685509片	Avenciguat	Tablet	Chemical Drugs(1)	Import Drug Application	2023-08-22					view
JXHL2300193	BI685509片	Avenciguat	Tablet	Chemical Drugs(1)	Import Drug Application	2023-08-22					view
JXHL2200207	BI685509片	Avenciguat	Tablet	Chemical Drugs(1)	Import Drug Application	2022-07-20					view
JXHL2200206	BI685509片	Avenciguat	Tablet	Chemical Drugs(1)	Import Drug Application	2022-07-20					view
JXHL2200205	BI685509片	Avenciguat	Tablet	Chemical Drugs(1)	Import Drug Application	2022-07-20					view
JXHL2200074	BI685509片	Avenciguat	Tablet	Chemical Drugs(1)	Import Drug Application	2022-04-01					view
JXHL2200073	BI685509片	Avenciguat	Tablet	Chemical Drugs(1)	Import Drug Application	2022-04-01					view
JXHL2200072	BI685509片	Avenciguat	Tablet	Chemical Drugs(1)	Import Drug Application	2022-04-01					view
JXHL2101224	BI685509片	Avenciguat	Tablet	Chemical Drugs(1)	Import Drug Application	2021-10-27					view
JXHL2101223	BI685509片	Avenciguat	Tablet	Chemical Drugs(1)	Import Drug Application	2021-10-27					view
JXHL2101222	BI685509片	Avenciguat	Tablet	Chemical Drugs(1)	Import Drug Application	2021-10-27					view
JXHL2100020	BI685509片	Avenciguat	Tablet	Chemical Drugs(1)	Import Drug Application	2021-01-19	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	In Review	2021-01-18	view
JXHL2100019	BI685509片	Avenciguat	Tablet	Chemical Drugs(1)	Import Drug Application	2021-01-19	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	In Review	2021-01-18	view
JXHL2100018	BI685509片	Avenciguat	Tablet	Chemical Drugs(1)	Import Drug Application	2021-01-19	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	In Review	2021-01-18	view
JXHB2400006	BI685509片	Avenciguat	Tablet	Chemical Drugs(1)	Supplementary Application	2024-01-04		Boehringer Ingelheim International GmbH			view
JXHB2400005	BI685509片	Avenciguat	Tablet	Chemical Drugs(1)	Supplementary Application	2024-01-04		Boehringer Ingelheim International GmbH			view
JXHB2400004	BI685509片	Avenciguat	Tablet	Chemical Drugs(1)	Supplementary Application	2024-01-04		Boehringer Ingelheim International GmbH			view
JXHB2200169	BI685509片	Avenciguat	Tablet	Chemical Drugs(1)	Supplementary Application	2022-11-03		Boehringer Ingelheim International GmbH			view
JXHB2200168	BI685509片	Avenciguat	Tablet	Chemical Drugs(1)	Supplementary Application	2022-11-03		Boehringer Ingelheim International GmbH			view